News Room

Stay up-to-date with the latest news from Repligen, including company announcements, product launches, industry insights, and upcoming events. Explore how we’re advancing innovation in bioprocessing and shaping the future of therapeutic manufacturing.

About Leadership Locations Careers Investors Sustainability

Contact

Repligen adds single-use filtration technology through TangenX acquisition

Dan Stanton BioPharma Reporter

Repligen pays $40 milion to buy TangenX™ Technology

Robert Weisman Boston Globe

Repligen Launches Single-use Version of its Cell Retention Technology

Dan Stanton BioPharma Reporter

Special Report on Continuous Bioprocessing: Upstream, Downstream, ready for Prime Time?

Angelo DePalma, BioProcessing International

Repligen to expand chromatography column production capacity in US and Europe

Dan Stanton BioPharma Reporter

Prepacked Chromatography Columns; Evaluation for Use in Pilot and Large-Scale Bioprecessing

Shaun Grier and Saani Yakubu BioProcess International

Repligen extends Protein A ligand supply deal with GE Healthcare

Dan Stanton BioPharma Reporter

OPUS® Columns win Design Excellence Awards: Winner - iF 2016 Design Excellence Award - Product

OPUS® Columns win Design Excellence Awards: Notable Mention - 2015 CORE77 Award for Design Excellence - Commercial Equipment

OPUS® Columns win Design Excellence Awards: Winner - GOOD DESIGN 2015 Award for Design Excellence - Industry

Announcing the 2014 North America Technology Fast 500™ Rankings: Annual ranking of fastest growing North America companies

Deloitte US

The Lowdown on Scale - Up Mismatches: Many of the Scale-Up Mismatches Can Be Avoided With Careful Planning

Angelo DePalma, Ph.D. Genetic Engineering News